ANKRD50 Antibody [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-50031JF549
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human, Mouse
Applications
Immunoprecipitation, Western Blot
Label
Janelia Fluor 549
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for ANKRD50 Antibody [Janelia Fluor® 549]
Immunogen
The immunogen for this product maps to a region between residue 1200 and 1250 of human Ankyrin Repeat Domain 50 using the numbering given in entry NP_065070.1 (GeneID 57182).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for ANKRD50 Antibody [Janelia Fluor® 549]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: ANKRD50
Alternate Names
ankyrin repeat domain 50
Gene Symbol
ANKRD50
Additional ANKRD50 Products
Product Documents for ANKRD50 Antibody [Janelia Fluor® 549]
Product Specific Notices for ANKRD50 Antibody [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...